Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.
Delaware Growth and Income A FGINX
- NAV / 1-Day Return 15.82 / +1.67 %
- Total Assets 1.1 Bil
-
Adj. Expense Ratio
- Expense Ratio 1.020%
- Distribution Fee Level Average
- Share Class Type Front Load
- Category Large Value
- Investment Style Large Value
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 2.10%
- Turnover 26%
USD | NAV as of Jul 26, 2024 | 1-Day Return as of Jul 26, 2024, 10:24 PM GMT+0
Morningstar’s Analysis FGINX
Will FGINX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 35.4
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Exxon Mobil Corp | 5.21 | 68.8 Mil | Energy |
Merck & Co Inc | 4.31 | 56.9 Mil | Healthcare |
Qualcomm Inc | 3.88 | 51.2 Mil | Technology |
The Cigna Group | 3.63 | 47.9 Mil | Healthcare |
Philip Morris International Inc | 3.60 | 47.5 Mil | Consumer Defensive |
Cisco Systems Inc | 3.44 | 45.4 Mil | Technology |
Corebridge Financial Inc | 2.88 | 38.0 Mil | Financial Services |
Broadcom Inc | 2.86 | 37.8 Mil | Technology |
Micron Technology Inc | 2.85 | 37.6 Mil | Technology |
Gilead Sciences Inc | 2.77 | 36.5 Mil | Healthcare |